Arthritis drug Orencia wins FDA approval

04/10/2008 | WebMD · MedPage Today (free registration)

Bristol-Myers Squibb Co.'s Orencia has been approved by the FDA to treat moderate-to-severe polyarticular juvenile idiopathic arthritis in patients over 6 years of age. The clearance is based on the findings of a large trial called AWAKEN, which showed a significant difference between Orencia and a placebo in improving symptoms of the condition.

View Full Article in:

WebMD · MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT